Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence
- PMID: 34677742
- PMCID: PMC8738141
- DOI: 10.1007/s10552-021-01506-1
Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence
Abstract
Purpose: There is increasing evidence that coffee consumption is related to reduced risks for some cancers, but the evidence for renal cancer is inconclusive. Therefore, we conducted a meta-analysis to summarize the cohort evidence of this relationship.
Methods: A literature search was performed in PubMed and Embase through February 2021. Meta-analyses using a random effects model were conducted for reported relative risk estimates (RRs) relating coffee intake and renal cancer incidence or mortality. We also performed a two-stage random effects exposure-response meta-analysis. Between-study heterogeneity was assessed.
Results: In a meta-analysis of the ten identified cohort studies, we found a summary RR of 0.88 [95% confidence interval (CI) 0.78-0.99] relating the highest vs. the lowest category of coffee intake and renal cancer, with no significant between-study heterogeneity observed (I2 = 35%, p = 0.13). This inverse association remained among studies of incident cancers (RR 0.85, 95% CI 0.76-0.96) and studies adjusting for smoking and body mass index (RR 0.87, 95% CI 0.77-0.99).
Conclusions: Our findings from this meta-analysis of the published cohort evidence are suggestive of an inverse association between coffee consumption and renal cancer risk.
Keywords: Coffee; Cohort study; Kidney cancer; Meta-analysis.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Conflict of interest statement
Conflict of interests/Competing interests: The authors declare no conflict of interest.
Figures
Similar articles
-
Association between coffee drinking and endometrial cancer risk: A meta-analysis.J Obstet Gynaecol Res. 2022 Mar;48(3):774-795. doi: 10.1111/jog.15139. Epub 2022 Jan 19. J Obstet Gynaecol Res. 2022. PMID: 35048465
-
Coffee consumption and the risk of incident gastric cancer--A meta-analysis of prospective cohort studies.Nutr Cancer. 2016;68(1):40-7. doi: 10.1080/01635581.2016.1115093. Epub 2015 Dec 28. Nutr Cancer. 2016. PMID: 26710312
-
A meta-analysis of coffee consumption and pancreatic cancer.Ann Oncol. 2012 Feb;23(2):311-8. doi: 10.1093/annonc/mdr331. Epub 2011 Jul 11. Ann Oncol. 2012. PMID: 21746805
-
Long-Term Coffee Consumption and Risk of Gastric Cancer: A PRISMA-Compliant Dose-Response Meta-Analysis of Prospective Cohort Studies.Medicine (Baltimore). 2015 Sep;94(38):e1640. doi: 10.1097/MD.0000000000001640. Medicine (Baltimore). 2015. PMID: 26402838 Free PMC article. Review.
-
Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies.BMC Cancer. 2020 Feb 5;20(1):101. doi: 10.1186/s12885-020-6561-9. BMC Cancer. 2020. PMID: 32024485 Free PMC article. Review.
Cited by
-
Association of diabetes risk reduction diet with renal cancer risk in 101,755 participants: a prospective study.J Transl Med. 2023 Oct 2;21(1):684. doi: 10.1186/s12967-023-04555-z. J Transl Med. 2023. PMID: 37784113 Free PMC article.
-
The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases.Molecules. 2023 Mar 4;28(5):2381. doi: 10.3390/molecules28052381. Molecules. 2023. PMID: 36903626 Free PMC article. Review.
-
The Epigenetic Effects of Coffee.Molecules. 2023 Feb 13;28(4):1770. doi: 10.3390/molecules28041770. Molecules. 2023. PMID: 36838754 Free PMC article. Review.
-
Health Benefits of Coffee Consumption for Cancer and Other Diseases and Mechanisms of Action.Int J Mol Sci. 2023 Jan 31;24(3):2706. doi: 10.3390/ijms24032706. Int J Mol Sci. 2023. PMID: 36769029 Free PMC article. Review.
-
Green tea and coffee consumption and risk of kidney cancer in Japanese adults.Sci Rep. 2022 Nov 24;12(1):20274. doi: 10.1038/s41598-022-24090-z. Sci Rep. 2022. PMID: 36434069 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68: 394–424. - PubMed
-
- Siegel RL, Miller KD, Jemal A. (2018) Cancer statistics, 2018. CA Cancer J Clin. 68: 7–30. - PubMed
-
- Howlader N, Noone AM, Krapcho M, et al. (April 2020) SEER Cancer Statistics Review, 1975–2017. National Cancer Institute. Bethesda, MD.
-
- Chow W-H, Devesa SS, Warren JL, Fraumeni JF Jr. (1999) Rising incidence of renal cell cancer in the United States. JAMA. 281: 1628–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
